by Lance Smith | Mar 23, 2020 | Study Scavenger Clinical Trial Recruitment Platform
HANGZHOU, China, March 23, 2020 (GLOBE NEWSWIRE) — AnHeart Therapeutics, Co., Ltd. (“AnHeart”), a clinical stage oncology company focused on underserved patients in global markets, today announced that its new drug candidate taletrectinib has received IND...by Lance Smith | Mar 23, 2020 | Study Scavenger Clinical Trial Recruitment Platform
Randomizations concluded and trial participation in process of concluding to ensure patient safety during COVID-19 pandemic AXS-05 and placebo arms fully enrolled with estimated completion rate of more than 90% Topline results now expected early 2Q 2020 NEW...by Lance Smith | Mar 23, 2020 | Study Scavenger Clinical Trial Recruitment Platform
VANCOUVER, British Columbia, March 20, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce today that it has...by Lance Smith | Mar 23, 2020 | Study Scavenger Clinical Trial Recruitment Platform
The Feinstein Institutes for Medical Research, the research arm of Northwell Health, announced today the enrollment of three clinical trials in the ongoing effort to combat COVID-19, the novel coronavirus. Feinstein Institutes researchers are teaming up with Gilead...by Lance Smith | Mar 23, 2020 | Study Scavenger Clinical Trial Recruitment Platform
WARREN, N.J., March 20, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has granted emergency expanded...